AstraZeneca Outbids Actelion to Land ZS Pharma
By Heather Cartwright & Keshav Mahawar
Pharma Deals Review: Vol 2015 Issue 12 (Table of Contents)
Published: 11 Dec-2015
DOI: 10.3833/pdr.v2015.i12.2135 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In a bid to offset declining revenues from its cardiovascular and metabolic diseases portfolio, AstraZeneca has agreed to acquire ZS Pharma in an all-cash transaction worth approximately US$2...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS